Litcius/Paper detail

Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials

Nicholas Marston, James P. Pirruccello, Giorgio Melloni, Frederick Kamanu, Marc P. Bonaca, Robert P. Giugliano, Benjamin M. Scirica, Stephen D. Wiviott, Deepak L. Bhatt, Philippe Gabríel Steg, Itamar Raz, Eugene Braunwald, Peter Libby, Patrick T. Ellinor, Alexander G. Bick, Marc S. Sabatine, Christian T. Ruff

2024Nature Medicine41 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineHazard ratioMyocardial infarctionStroke (engine)PopulationRandomized controlled trialClinical trialCardiologyConfidence intervalMechanical engineeringEnvironmental healthEngineeringAcute Myeloid Leukemia ResearchChronic Lymphocytic Leukemia ResearchDiabetes Treatment and Management
Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials | Litcius